Michael Berntgen

Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit

R Gröning, Michael Berntgen, M. Georgarakis · European Journal of Pharmaceutics and Biopharmaceutics · 1998 · 87 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +10

Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments—A Collaboration between the European Medicines Agency and the European network for Health Technology Assessment

Michael Berntgen, Anne Gourvil, Mira Pavlovic et al. · Value in Health · 2014 · 47 citations

Pharmacy, Health Policy, Pharmaceutical Policy +10

Estimation of the gastric residence time of magnetic dosage forms using the Heidelberg capsule.

R Gröning, Michael Berntgen · PubMed · 1996 · 18 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

The role of stakeholder involvement in the evolving EU HTA process: <i>Insights generated through the European Access Academy’s multi-stakeholder pre-convention questionnaire</i>

Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet et al. · Journal of Market Access & Health Policy · 2023 · 15 citations · Full text

Management, Health Policy, Regulatory Policy +16

Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy

Francine Brinkhuis, Elaine Julian, Hendrika van den Ham et al. · Health Research Policy and Systems · 2024 · 10 citations · Full text

Public Affairs, Health Policy, Regulatory Policy +16